UniProt ID | PTPR2_HUMAN | |
---|---|---|
UniProt AC | Q92932 | |
Protein Name | Receptor-type tyrosine-protein phosphatase N2 | |
Gene Name | PTPRN2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1015 | |
Subcellular Localization |
Cytoplasmic vesicle, secretory vesicle membrane Single-pass type I membrane protein . Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane Single-pass type I membrane protein . Predominantly found on dense-core secretory granules. So |
|
Protein Description | Plays a role in vesicle-mediated secretory processes. Required for normal accumulation of secretory vesicles in hippocampus, pituitary and pancreatic islets. Required for the accumulation of normal levels of insulin-containing vesicles and preventing their degradation. Plays a role in insulin secretion in response to glucose stimuli. Required for normal accumulation of the neurotransmitters norepinephrine, dopamine and serotonin in the brain. In females, but not in males, required for normal accumulation and secretion of pituitary hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (By similarity). Required to maintain normal levels of renin expression and renin release (By similarity). May regulate catalytic active protein-tyrosine phosphatases such as PTPRA through dimerization (By similarity). Has phosphatidylinositol phosphatase activity; the PIPase activity is involved in its ability to regulate insulin secretion. Can dephosphorylate phosphatidylinositol 4,5-biphosphate (PI(4,5)P2), phosphatidylinositol 5-phosphate and phosphatidylinositol 3-phosphate (By similarity). Regulates PI(4,5)P2 level in the plasma membrane and localization of cofilin at the plasma membrane and thus is indirectly involved in regulation of actin dynamics related to cell migration and metastasis; upon hydrolyzation of PI(4,5)P2 cofilin is released from the plasma membrane and acts in the cytoplasm in severing F-actin filaments. [PubMed: 26620550] | |
Protein Sequence | MGPPLPLLLLLLLLLPPRVLPAAPSSVPRGRQLPGRLGCLLEEGLCGASEACVNDGVFGRCQKVPAMDFYRYEVSPVALQRLRVALQKLSGTGFTWQDDYTQYVMDQELADLPKTYLRRPEASSPARPSKHSVGSERRYSREGGAALANALRRHLPFLEALSQAPASDVLARTHTAQDRPPAEGDDRFSESILTYVAHTSALTYPPGSRTQLREDLLPRTLGQLQPDELSPKVDSGVDRHHLMAALSAYAAQRPPAPPGEGSLEPQYLLRAPSRMPRPLLAPAAPQKWPSPLGDSEDPSSTGDGARIHTLLKDLQRQPAEVRGLSGLELDGMAELMAGLMQGVDHGVARGSPGRAALGESGEQADGPKATLRGDSFPDDGVQDDDDRLYQEVHRLSATLGGLLQDHGSRLLPGALPFARPLDMERKKSEHPESSLSSEEETAGVENVKSQTYSKDLLGQQPHSEPGAAAFGELQNQMPGPSKEEQSLPAGAQEALSDGLQLEVQPSEEEARGYIVTDRDPLRPEEGRRLVEDVARLLQVPSSAFADVEVLGPAVTFKVSANVQNVTTEDVEKATVDNKDKLEETSGLKILQTGVGSKSKLKFLPPQAEQEDSTKFIALTLVSLACILGVLLASGLIYCLRHSSQHRLKEKLSGLGGDPGADATAAYQELCRQRMATRPPDRPEGPHTSRISSVSSQFSDGPIPSPSARSSASSWSEEPVQSNMDISTGHMILSYMEDHLKNKNRLEKEWEALCAYQAEPNSSFVAQREENVPKNRSLAVLTYDHSRVLLKAENSHSHSDYINASPIMDHDPRNPAYIATQGPLPATVADFWQMVWESGCVVIVMLTPLAENGVRQCYHYWPDEGSNLYHIYEVNLVSEHIWCEDFLVRSFYLKNLQTNETRTVTQFHFLSWYDRGVPSSSRSLLDFRRKVNKCYRGRSCPIIVHCSDGAGRSGTYVLIDMVLNKMAKGAKEIDIAATLEHLRDQRPGMVQTKEQFEFALTAVAEEVNAILKALPQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
25 | Phosphorylation | RVLPAAPSSVPRGRQ CCCCCCCCCCCCCCC | 38.96 | - | |
26 | Phosphorylation | VLPAAPSSVPRGRQL CCCCCCCCCCCCCCC | 34.77 | - | |
124 | Phosphorylation | LRRPEASSPARPSKH HCCCCCCCCCCCCCC | 29.62 | - | |
129 | Phosphorylation | ASSPARPSKHSVGSE CCCCCCCCCCCCCCC | 37.13 | - | |
139 | Phosphorylation | SVGSERRYSREGGAA CCCCCCCCCHHHHHH | 20.50 | - | |
199 | Phosphorylation | ILTYVAHTSALTYPP HHHHHHHHHCCCCCC | 13.12 | - | |
220 | Phosphorylation | REDLLPRTLGQLQPD HHHHHHHCCCCCCCC | 33.04 | 24719451 | |
220 | O-linked_Glycosylation | REDLLPRTLGQLQPD HHHHHHHCCCCCCCC | 33.04 | 101008221 | |
230 | Phosphorylation | QLQPDELSPKVDSGV CCCCCCCCCCCCCCC | 22.19 | 24719451 | |
230 | O-linked_Glycosylation | QLQPDELSPKVDSGV CCCCCCCCCCCCCCC | 22.19 | 101008229 | |
247 | Phosphorylation | HHLMAALSAYAAQRP HHHHHHHHHHHHHCC | 17.95 | - | |
249 | Phosphorylation | LMAALSAYAAQRPPA HHHHHHHHHHHCCCC | 10.09 | - | |
360 | Phosphorylation | GRAALGESGEQADGP CCCCCCCCCCCCCCC | 45.92 | 26657352 | |
375 | Phosphorylation | KATLRGDSFPDDGVQ CCCCCCCCCCCCCCC | 41.31 | 26657352 | |
398 | O-linked_Glycosylation | EVHRLSATLGGLLQD HHHHHHHHHHHHHHH | 23.66 | 55831127 | |
428 | Phosphorylation | LDMERKKSEHPESSL CCCCHHHCCCCCCCC | 44.14 | 29691806 | |
433 | Phosphorylation | KKSEHPESSLSSEEE HHCCCCCCCCCCHHH | 40.82 | 29691806 | |
434 | Phosphorylation | KSEHPESSLSSEEET HCCCCCCCCCCHHHH | 30.52 | 26657352 | |
436 | Phosphorylation | EHPESSLSSEEETAG CCCCCCCCCHHHHHC | 37.34 | 26657352 | |
437 | Phosphorylation | HPESSLSSEEETAGV CCCCCCCCHHHHHCC | 55.08 | 26657352 | |
441 | Phosphorylation | SLSSEEETAGVENVK CCCCHHHHHCCCCHH | 31.80 | 29691806 | |
516 (in isoform 2) | O-linked_Glycosylation | - | 18.76 | OGP | |
526 (in isoform 2) | O-linked_Glycosylation | - | 20.53 | OGP | |
564 | N-linked_Glycosylation | KVSANVQNVTTEDVE EEECCCEECCHHHHH | 28.90 | UniProtKB CARBOHYD | |
592 | Phosphorylation | SGLKILQTGVGSKSK HCCEEEECCCCCHHH | 30.32 | 22210691 | |
596 | Phosphorylation | ILQTGVGSKSKLKFL EEECCCCCHHHCEEC | 31.20 | 22210691 | |
598 | Phosphorylation | QTGVGSKSKLKFLPP ECCCCCHHHCEECCC | 44.94 | 24719451 | |
619 | Phosphorylation | STKFIALTLVSLACI CHHHHHHHHHHHHHH | 18.98 | - | |
622 | Phosphorylation | FIALTLVSLACILGV HHHHHHHHHHHHHHH | 17.23 | - | |
643 | Phosphorylation | IYCLRHSSQHRLKEK HHHHHHCCHHHHHHH | 24.71 | - | |
666 | Phosphorylation | GADATAAYQELCRQR CHHHHHHHHHHHHHH | 10.47 | 25884760 | |
691 | Phosphorylation | GPHTSRISSVSSQFS CCCCCCCCCCCCCCC | 24.47 | 27251275 | |
692 | Phosphorylation | PHTSRISSVSSQFSD CCCCCCCCCCCCCCC | 24.52 | 26657352 | |
694 | Phosphorylation | TSRISSVSSQFSDGP CCCCCCCCCCCCCCC | 21.99 | 27251275 | |
695 | Phosphorylation | SRISSVSSQFSDGPI CCCCCCCCCCCCCCC | 32.84 | 27251275 | |
698 | Phosphorylation | SSVSSQFSDGPIPSP CCCCCCCCCCCCCCC | 33.74 | 26657352 | |
704 | Phosphorylation | FSDGPIPSPSARSSA CCCCCCCCCCCCCCC | 32.01 | 26657352 | |
713 | Phosphorylation | SARSSASSWSEEPVQ CCCCCCCCCCCCCCC | 34.05 | 23286773 | |
776 | Phosphorylation | ENVPKNRSLAVLTYD HCCCCCCEEEEEEEC | 30.03 | 23312004 | |
782 | Phosphorylation | RSLAVLTYDHSRVLL CEEEEEEECCHHEEE | 13.90 | 26503514 | |
934 | Phosphorylation | RRKVNKCYRGRSCPI HHHHHHHHCCCCCCE | 20.08 | 29457462 | |
941 | Acetylation | YRGRSCPIIVHCSDG HCCCCCCEEEECCCC | 6.36 | 19608861 | |
953 | Acetylation | SDGAGRSGTYVLIDM CCCCCCCCCHHHHHH | 21.50 | 19608861 | |
970 | Acetylation | NKMAKGAKEIDIAAT HHHHCCCCCCCHHHH | 64.96 | 19608861 | |
977 | Phosphorylation | KEIDIAATLEHLRDQ CCCCHHHHHHHHHHC | 24.53 | 18187866 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PTPR2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTPR2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTPR2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SPTN4_HUMAN | SPTBN4 | physical | 11086001 | |
CKAP5_HUMAN | CKAP5 | physical | 12421765 | |
INT11_HUMAN | CPSF3L | physical | 27880917 | |
MON2_HUMAN | MON2 | physical | 27880917 | |
MSPD2_HUMAN | MOSPD2 | physical | 27880917 | |
S61A1_HUMAN | SEC61A1 | physical | 27880917 | |
SORT_HUMAN | SORT1 | physical | 27880917 | |
TELO2_HUMAN | TELO2 | physical | 27880917 | |
HID1_HUMAN | HID1 | physical | 27880917 | |
SNX19_HUMAN | SNX19 | physical | 27880917 | |
K1C17_HUMAN | KRT17 | physical | 27880917 | |
HGS_HUMAN | HGS | physical | 27880917 | |
K1C16_HUMAN | KRT16 | physical | 27880917 | |
STAM1_HUMAN | STAM | physical | 27880917 | |
GRP78_HUMAN | HSPA5 | physical | 27880917 | |
STIM1_HUMAN | STIM1 | physical | 27880917 | |
CLCC1_HUMAN | CLCC1 | physical | 27880917 | |
STAM2_HUMAN | STAM2 | physical | 27880917 | |
K1C14_HUMAN | KRT14 | physical | 27880917 | |
GOGA4_HUMAN | GOLGA4 | physical | 27880917 | |
ANKL2_HUMAN | ANKLE2 | physical | 27880917 | |
NU155_HUMAN | NUP155 | physical | 27880917 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-970, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-977, AND MASSSPECTROMETRY. |